C3-Activating proteases on human lymphoblastoid cells superinfected with epstein-barr virus
- 30 April 1980
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 51 (1), 168-172
- https://doi.org/10.1016/0008-8749(80)90246-4
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (NIH-NOl-CO-65341)
This publication has 11 references indexed in Scilit:
- Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein‐Barr virus transformation of the cellsEuropean Journal of Immunology, 1978
- Complement bridges between cells analysis of a possible cell-cell interaction mechanism.The Journal of Experimental Medicine, 1977
- Malignancy and Transformation: Expression in Somatic Cell Hybrids and VariantsAdvances in Cancer Research, 1977
- Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of ebv-negative lymphoma lines and theirin vitro EBV-converted sublinesInternational Journal of Cancer, 1976
- Third component of human complement: purification from plasma and physicochemical characterizationBiochemistry, 1976
- Epstein-Barr virus (EBV)-induced change in the saturation sensitivity and serum dependence of established, EBV-negative lymphoma lines in vitroVirology, 1976
- Difference in antibody induced redistribution of membrane IgM in EBV-genome free and EBV positive human lymphoid cellsExperimental Cell Research, 1976
- Production by EBV infection of an EBNA‐positive subline from an EBNA‐negative human lymphoma cell line without detectable EBV DNAInternational Journal of Cancer, 1975
- AN ENZYMATIC FUNCTION ASSOCIATED WITH TRANSFORMATION OF FIBROBLASTS BY ONCOGENIC VIRUSESThe Journal of Experimental Medicine, 1973
- ISOLATION OF A FRAGMENT (C3a) OF THE THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUMThe Journal of Experimental Medicine, 1969